Nigeria Kicks-Off Phase Two Of Vaccination Programme With Moderna

The Presidential Steering Committee (PSC) on COVID-19 on Monday
commenced the rollout of phase two of the vaccination programme
with 4,000,080 Moderna vaccines doses donated by the United State
of America (USA).

The phase two COVID-19 vaccination exercise, anchored by the
National Primary Health Care Development Agency (NPHCDA), was
kick-started at the Federal Medical Centre, Jabi, Abuja.

The Moderna vaccines consignment, which was brought in through
COVAX, the international aid initiative that seeks to ensure global
access to vaccines, is part of the 500 million doses of vaccines
President Joe Biden promised to donate to the global fight against
COVID-19 between now and end of 2022.

The initiative is part of the collaboration between the African
Vaccine Acquisition Trust (AVAT), COVAX, and the US government,
with the African Union Member States set to receive about 25
million COVID-19 vaccine doses to enhance coverage across the
continent and vaccinate at least 60 percent of the African
population.

The National Agency for Food and Drug Administration and Control
(NAFDAC) has granted emergency use authorisation for three COVID-19
vaccines – Moderna, AstraZeneca (from Korea) and Sputnik V.

The AstraZeneca approved is from Korea due to the stall in the
procurement of AstraZeneca vaccine also known as Covishield
manufactured under licence by Serum Institute of India due to the
COVID-19 pandemic in the country.

The NAFDAC had previously approved AstraZeneca (India), Pfizer
bioNTech and Johnson & Johnson COVID-19 vaccines in February and
May 2021 respectively.

Secretary to the Government of the Federation (SGF) and Chairman
of the PSC, Mr. Boss Mustapha, warned against hoarding COVID-19
vaccines, especially now that the number of cases of infection are
soaring.

He also commended all Nigerians, especially those who have
received their full two doses of the AstraZeneca vaccine during the
first phase which closed in July.

He pledged the PSC will continue to monitor the increasing trend
of COVID-19 cases in several countries with a special focus on
those with high incidence rates and widespread prevalence of
variants of concern.

The Presidential Steering Committee (PSC) on COVID-19 on Monday
commenced the rollout of phase two of the vaccination programme
with 4,000,080 Moderna vaccines doses donated by the United State
of America (USA).

The phase two COVID-19 vaccination exercise, anchored by the
National Primary Health Care Development Agency (NPHCDA), was
kick-started at the Federal Medical Centre, Jabi, Abuja.

The Moderna vaccines consignment, which was brought in through
COVAX, the international aid initiative that seeks to ensure global
access to vaccines, is part of the 500 million doses of vaccines
President Joe Biden promised to donate to the global fight against
COVID-19 between now and end of 2022.

The initiative is part of the collaboration between the African
Vaccine Acquisition Trust (AVAT), COVAX, and the US government,
with the African Union Member States set to receive about 25
million COVID-19 vaccine doses to enhance coverage across the
continent and vaccinate at least 60 percent of the African
population.

The National Agency for Food and Drug Administration and Control
(NAFDAC) has granted emergency use authorisation for three COVID-19
vaccines – Moderna, AstraZeneca (from Korea) and Sputnik V.

The AstraZeneca approved is from Korea due to the stall in the
procurement of AstraZeneca vaccine also known as Covishield
manufactured under licence by Serum Institute of India due to the
COVID-19 pandemic in the country.

The NAFDAC had previously approved AstraZeneca (India), Pfizer
bioNTech and Johnson & Johnson COVID-19 vaccines in February and
May 2021 respectively.

Secretary to the Government of the Federation (SGF) and Chairman
of the PSC, Mr. Boss Mustapha, warned against hoarding COVID-19
vaccines, especially now that the number of cases of infection are
soaring.

He also commended all Nigerians, especially those who have
received their full two doses of the AstraZeneca vaccine during the
first phase which closed in July.

He pledged the PSC will continue to monitor the increasing trend
of COVID-19 cases in several countries with a special focus on
those with high incidence rates and widespread prevalence of
variants of concern.